Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal Zostavax in HSCT Donors
NCT02329457Phase 3Completed
- Sponsor
- The University of Hong Kong
- Start
- Dec 2014
- Primary completion
- Sep 2019
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of zoster vaccine, live in herpes zoster (HZ), sponsored by The University of Hong Kong. Started Dec 2014; status: completed.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT02329457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02329457.